What is China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (000999.SZ) StockRank?

MoatMap's StockRank for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) is 87/100, with a Strong Buy signal. This is a composite score combining Quality (66), Value (60), and Momentum (49) factor ranks across MoatMap's 19,000+ stock universe.

Does China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. have an economic moat?

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) has a Quality factor score of 66/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) is Strong Buy, based on a StockRank of 87/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. in?

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

000999.SZ

STRONG BUYREMOVE

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. · Healthcare · China · $6.0B · Avg Vol: $35M/d

StockRank

P/E (TTM)

12.6x

ROE

10.8%

D/E

0.1x

Dividend %

4.2%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

China Resources Sanjiu is a leading OTC traditional Chinese medicine player, but it operates in a highly regulated domestic market with limited global scalability. It does not align with our core global macro themes and carries significant domestic regulatory risk.

COMPANY DESCRIPTION

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. manufactures and markets over-the-counter (OTC) drugs and Traditional Chinese Medicine (TCM) prescription products. The company commands the leading position in China's OTC market, anchored by the highly recognized '999' brand. It is a consumer healthcare powerhouse with unmatched brand equity and an extensive retail pharmacy distribution network.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	2.7B	3.7B	4.1B	4.7B	20.5%
EPS	0.22	0.25	0.30	0.30	12.0%
Shares	1.7B	1.7B	1.7B	1.7B	-0.4%
Debt	58M	441M	193M	953M	154.6%
Equity	2.5B	2.8B	2.9B	3.3B	9.2%
Op CF	444M	620M	651M	815M	22.4%
Inv CF	-366M	-117M	-167M	-1.1B	—
Fin CF	-85M	67M	-684M	231M	—

PRICE (1M)-5.2%

SMA 50SMA 200

$3.63

RSI (14)

62.5

52W High

$4.72

From 52W High

0.8%

SCORE BREAKDOWN

Quality

ROIC

11.5%77.5

ROE

10.8%73.9

GP/Assets

30.9%66.4

Op. Margin

19.0%81.0

FCF/Assets

-2.4%42.6

Piotroski

—83.5

Int. Cover

42.4x81.6

D/E Ratio

0.14x59.4

Current Ratio

2.03x37.3

Value

P/E (TTM)

12.6x81.3

EV/EBITDA

9.9x42.3

P/FCF

—N/A

P/B

1.7x60.2

P/S

1.2x80.1

Div Yield

4.2%86.4

Momentum

52W High %

77%69.2

RS 6M

-20%54.8

SMA 50/200

0.92x40.7

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

+26%37.5

Q Growth

-15%27.8

FUNDAMENTALS

Market Cap

$6.0B

P/E (Forward)

10.0x

Gross Margin

55.0%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 000999.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
000999.SZ	China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.(you)	$6.0B	87	STRONG BUY
600329.SS	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited	$4.6B	87	STRONG BUY
000963.SZ	Huadong Medicine Co., Ltd	$7.5B	84	STRONG BUY
600535.SS	Tasly Pharmaceutical Group Co., Ltd	$3.1B	86	STRONG BUY
000513.SZ	Livzon Pharmaceutical Group Inc.	$4.0B	94	STRONG BUY
2096.HK	Simcere Pharmaceutical Group Limited	$3.3B	91	STRONG BUY
000423.SZ	Dong-E-E-Jiao Co., Ltd.	$4.8B	99	STRONG BUY
002603.SZ	Shijiazhuang Yiling Pharmaceutical Co., Ltd.	$4.0B	96	STRONG BUY
600062.SS	China Resources Double-Crane Pharmaceutical Co.,Ltd.	$2.6B	89	STRONG BUY
000739.SZ	Apeloa Pharmaceutical Co.,Ltd	$2.8B	91	STRONG BUY

Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.0%

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) — Stock Score Summary

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) has a MoatMap StockRank of 87/100 based on Quality (66/100), Value (60/100), and Momentum (49/100) factor scores. The current signal is STRONG BUY. China Resources Sanjiu is a leading OTC traditional Chinese medicine player, but it operates in a highly regulated domestic market with limited global scalability. It does not align with our core global macro themes and carries significant domestic regulatory risk.

Key Financial Metrics

Price	$3.63
Market Cap	$6.0B
P/E (TTM)	12.59
P/E (Forward)	10.03
Price/Book	1.75
Return on Equity	10.8%
Return on Invested Capital	11.5%
Debt/Equity	14.35
Gross Margin	55.0%
Operating Margin	19.0%
Revenue Growth	18.6%
Dividend Yield	4.2%
Free Cash Flow	$-31M

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.’s (000999.SZ) StockRank?: MoatMap’s StockRank for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) is 87/100, with a Strong Buy signal. It is a composite of Quality (66), Value (60), and Momentum (49) factor ranks across MoatMap’s 19,000+ stock universe.
Does China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. have an economic moat?: China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) has a Quality factor score of 66/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) is Strong Buy, based on a StockRank of 87/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. in?: China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).